$400 Savings Ends in:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Agenda for Day 2 – Thursday December 10, 2026 - US/Eastern
As regulatory expectations continue to rise, pharmacies must move beyond minimum compliance requirements and establish quality systems capable of supporting long-term growth.
Discussion Topics
Inspection readiness strategies
CAPA effectiveness
Documentation practices
Quality culture development
Long-term compliance sustainability
- Arpita Sammons - Director, Quality and Regulatory Compliance, Curexa
- Victor Hill - Director of Quality, Vios Compounding
- Jamal Almustapha - Vice President of Quality, Strive Pharmacy
Compliance investments can strengthen long-term viability—but only when aligned with operational realities and business objectives.
Discussion Topics
Financial realities of cGMP, QA and infrastructure investment
Long-term defensibility
Scaling quality systems
Avoiding overbuilding or underbuilding
Balancing compliance and profitability
- David Medina - Assistant Compliance Officer, Americare Pharmaceutical Services
Veterinary compounding remains a growing area of opportunity but presents unique regulatory and operational considerations.
Discussion Topics
Regulatory expectations
Quality considerations
Veterinary prescribing practices
Species-specific challenges
Market opportunities
- Erika Fallon - Pharmacist and Owner, Fallon Wellness Pharmacy
- Lawrence Rossetti - Chief Executive Officer, Drug Crafters Pharmacy
- Norman Petty - General Counsel and EVP, Business Affairs, Noom
- Learn how to navigate critical USP <797> and <800> compliance requirements, including facility design, environmental monitoring, and personnel training
- Discover how to implement robust standard operating procedures, quality assurance protocols, and effective risk assessments
- Master environmental monitoring programs and quality control strategies to ensure patient safety
- Prepare for regulatory inspections with actionable documentation and readiness best practices
- Adapt sterile compounding operations to meet evolving regulatory expectations
Join peers for facilitated, discussions focused on the strategic, operational, and compliance challenges shaping the future of compounding. Attendees will participate in small-group conversations designed to encourage candid dialogue, practical problem-solving, and peer-to-peer knowledge sharing.
Roundtable Topics
Emerging Business Models: Telehealth, Med Spas, Veterinary, and Other Growth Opportunities
Navigating Inspections, Audits, and State Board Expectations
Quality Systems That Scale: Balancing Compliance, Efficiency, and Growth
Peptides, GLP-1s, and Other High-Interest Compounded Therapies
Supply Chain, Sourcing, and Distribution Challenges Across Compounding
Preparing for What’s Next: Industry Trends, Market Pressures, and Strategic Priorities
- Scott Welch - President, Preston’s Pharmacy